Treatment outcomes in patients with relapsed Graves’ disease

In simple terms

This study watched what happened to people who picked different treatments for their thyroid problem, but didn’t randomly assign them. So we can say one group tended to feel better longer, but we don’t know if it was because of the medicine or because those people were different in other ways.

52%

Analysis score

52/ 72

Maximum 72 for a cohort study.

Where the score came from

Reporting40

Methodology51

Publication100

Statistical23

Study type (basis of the score)

Cohort Study

Level 2b - Individual cohort study

What’s the bottom line?

When Graves’ disease comes back after initial treatment, doctors can give more medicine, use radiation, or try again with medicine. This study looked at which works best over many years.

Where does this study sit?

Reviews of RCTs (Meta-analyses)

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5

StrongerWeaker

Cohort Studies

Level 2b

52 / 100

Quality score

Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.

Cannot establish causation

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Key takeaways

Summary

Based on the study abstract and findings.

1Yes — staying on a tiny daily pill kept thyroid levels stable better than radiation or stopping medicine after a second round.
2Patients on low-dose daily medicine stayed normal 79% of the time; those who took medicine again and then stopped had a 45% chance of getting sick again.

Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data